Manufacturer copay assistance · Actemra (J3262) · Genentech
$5/dose · Maximum benefit Up to $15,000 per calendar year · Covers Actemra drug cost only — does not cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Actemra — the program's cap applies against the patient share CareCost calculates.
Yes — Genentech Co-pay Assistance Program from Genentech. Patient pays $5 per infusion. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $5 per infusion Maximum benefit: Up to $15,000 per calendar year. Covers Actemra drug cost only — does not cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, government. Income limit: ≤400% FPL (~$62,600 single / ~$84,400 family of 2).
Yes — enrollment can be backdated 180 days from enrollment date. Timely filing: 365 days from date of service.